99 related articles for article (PubMed ID: 25939640)
1. Prognostic value of semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer.
Yoon HJ; Kim Y; Chang KT; Kim BS
Ann Nucl Med; 2015 Aug; 29(7):553-60. PubMed ID: 25939640
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of primary tumor SUV
Yoo J; Yoon HJ; Kim BS
Ann Nucl Med; 2017 Jan; 31(1):19-28. PubMed ID: 27645144
[TBL] [Abstract][Full Text] [Related]
3. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
Yoo J; Kim BS; Yoon HJ
Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
Kim BS; Sung SH
Ann Nucl Med; 2012 Feb; 26(2):175-83. PubMed ID: 22139552
[TBL] [Abstract][Full Text] [Related]
5. Correlations between Tumor to Background Ratio on Breast-Specific Gamma Imaging and Prognostic Factors in Breast Cancer.
Lee SJ; Choi YY; Kim C; Chung MS
J Korean Med Sci; 2017 Jun; 32(6):1031-1037. PubMed ID: 28480663
[TBL] [Abstract][Full Text] [Related]
6. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.
Brem RF; Floerke AC; Rapelyea JA; Teal C; Kelly T; Mathur V
Radiology; 2008 Jun; 247(3):651-7. PubMed ID: 18487533
[TBL] [Abstract][Full Text] [Related]
7. Comparison of
Liu H; Zhan H; Sun D
BMC Cancer; 2020 May; 20(1):463. PubMed ID: 32448217
[TBL] [Abstract][Full Text] [Related]
8. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
[TBL] [Abstract][Full Text] [Related]
9. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
[TBL] [Abstract][Full Text] [Related]
10. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
11. Relative Uptake Factor of Invasive Ductal Breast Cancer in Breast-specific Gamma Imaging as a Surrogate Parameter for Sub-typing.
Meissnitzer T; Meissnitzer MW; Seymer A; Hergan K; Neureiter D
Anticancer Res; 2015 Oct; 35(10):5671-7. PubMed ID: 26408742
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Song BI; Lee SW; Jeong SY; Chae YS; Lee WK; Ahn BC; Lee J
J Nucl Med; 2012 Sep; 53(9):1337-44. PubMed ID: 22870824
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
14. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia.
Papantoniou V; Valsamaki P; Sotiropoulou E; Tsaroucha A; Tsiouris S; Sotiropoulou M; Marinopoulos S; Kounadi E; Karianos T; Fothiadaki A; Archontaki A; Syrgiannis K; Ptohis N; Makris N; Limouris G; Antsaklis A
Mol Imaging; 2011 Oct; 10(5):370-6. PubMed ID: 21521552
[TBL] [Abstract][Full Text] [Related]
15. Relationship between parameters from virtual touch tissue quantification (VTQ) imaging with clinicopathologic prognostic factors in women with invasive ductal breast cancer.
Xie J; Wu R; Xu HX; Yao MH; Xu G
Int J Clin Exp Pathol; 2014; 7(10):6644-52. PubMed ID: 25400743
[TBL] [Abstract][Full Text] [Related]
16. Visual and semi-quantitative analyses of dual-phase breast-specific gamma imaging with Tc-99m-sestamibi in detecting primary breast cancer.
Tan H; Jiang L; Gu Y; Xiu Y; Han L; Wu P; Zhang H; Shi H
Ann Nucl Med; 2014 Jan; 28(1):17-24. PubMed ID: 24142630
[TBL] [Abstract][Full Text] [Related]
17. Does 99mTc-sestamibi uptake discriminate breast tumors?
Cayre A; Cachin F; Maublant J; Mestas D; Penault-Llorca F
Cancer Invest; 2004; 22(4):498-504. PubMed ID: 15565806
[TBL] [Abstract][Full Text] [Related]
18. MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial.
Keto JL; Kirstein L; Sanchez DP; Fulop T; McPartland L; Cohen I; Boolbol SK
Ann Surg Oncol; 2012 Jan; 19(1):249-52. PubMed ID: 21739318
[TBL] [Abstract][Full Text] [Related]
19. Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography.
Tolmos J; Khalkhali I; Vargas H; Stuntz M; Cutrone J; Mishkin F; Diggles L; Venegas R; Klein S
Am Surg; 1997 Oct; 63(10):850-3. PubMed ID: 9322655
[TBL] [Abstract][Full Text] [Related]
20. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
Dunnwald LK; Gralow JR; Ellis GK; Livingston RB; Linden HM; Lawton TJ; Barlow WE; Schubert EK; Mankoff DA
Cancer; 2005 Feb; 103(4):680-8. PubMed ID: 15637688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]